Zhang R, Wang ZY, Li YH, et al. Dynamic contrast-enhanced MRI to predict response to vinorelbine-cisplatin alone or with rh-endostatin in patients with non-small cell lung cancer and bone metastases: a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2016,388 Suppl 1:S95.